Sean Maduck - Sep 1, 2021 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Chief Commercial Officer
Signature
/s/ Joseph Douglas Lyon, Attorney-in-Fact for Sean Nicholas
Stock symbol
CORT
Transactions as of
Sep 1, 2021
Transactions value $
-$452,680
Form type
4
Date filed
9/3/2021, 05:10 PM
Previous filing
Aug 5, 2021
Next filing
Oct 5, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Options Exercise $82.3K +25K +62.46% $3.29* 65K Sep 1, 2021 Direct F1
transaction CORT Common Stock Sale -$535K -25K -38.45% $21.40 40K Sep 1, 2021 Direct F1, F2
holding CORT Common Stock 10K Sep 1, 2021 See Footnote F3
holding CORT Common Stock 10K Sep 1, 2021 See Footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORT Stock Option (Right to Buy) Options Exercise $0 -25K -14.48% $0.00 148K Sep 1, 2021 Common Stock 25K $3.29 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was made pursuant to a 10b5-1 plan in effect at the time of the transaction.
F2 Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $21.38 to $21.445 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
F3 Represents the shares held by Duckhill Capital, LLC of which the reporting person is President and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
F4 Represents the shares held by Sean and Molly Maduck Living Trust of which the reporting person is a co-trustee.
F5 Fully exercisable.